Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

606

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Hemorrhagic Fever, Ebola
Interventions
OTHER

Convalescent Plasma

Patients will be treated with plasma from recovered EVD patients.

Trial Locations (1)

Unknown

Ebola Treatment Center, Donka

All Listed Sponsors
collaborator

National Blood Transfusion Centre (NBTC), Conakry, Guinea

UNKNOWN

collaborator

Gamal Abdel Nasser University of Conakry

OTHER

collaborator

National Center for Training and Research of Maferinyah, Guinea

UNKNOWN

collaborator

Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

OTHER

collaborator

University of Oxford

OTHER

collaborator

University of Liverpool

OTHER

collaborator

London School of Hygiene and Tropical Medicine

OTHER

collaborator

Aix Marseille Université

OTHER

collaborator

UBIVE, Institut Pasteur, Paris, France

UNKNOWN

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Etablissement Français du Sang

OTHER

collaborator

Belgian Red Cross

OTHER

collaborator

Institut Pasteur, Dakar, Sénégal

UNKNOWN

collaborator

Médecins Sans Frontières, Belgium

OTHER

collaborator

World Health Organization

OTHER

collaborator

International Severe Acute Respiratory and Emerging Infection Consortium

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT02342171 - Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea | Biotech Hunter | Biotech Hunter